Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide +/- Rituximab Maintenance in DLBCL
NCT00765245Phase 2Completed
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- Oct 2008
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in diffuse large B-cell lymphoma (DLBCL), sponsored by Vanderbilt-Ingram Cancer Center. Started Oct 2008; status: completed.
02
Drugs
lenalidomide
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00765245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00765245.